FDA Clearance Tracker · P980031-S007
INTACS PRESCRIPTION INSERTS
Last checked: Nov 20, 2026Latest source record: Aug 21, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Aug 21, 2007
Approved
Time to decision
1,189 days
Received May 19, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P980031-S007
- Device name
- INTACS PRESCRIPTION INSERTS
- Applicant
- Addition Technology
- Applicant location
- Lombard, IL
- Received
- May 19, 2004
- Decided
- Aug 21, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P980031
Device type
- Device type
- Implant, corneal, refractive (LQE)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR PACKAGING OPERATIONS FOR THE INTACS PRESCRIPTION INSERTS TO BE TRANSFERRED TO THE SUNNYVALE, CALIFORNIA FACILITY.
Source documents
Other decisions for Addition Technology
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.